Increased genitourinary fistula rate after bevacizumab in recurrent cervical cancer patients initially treated with definitive radiochemotherapy and image-guided adaptive brachytherapy

BACKGROUND AND PURPOSE: Patients with recurrent cervical cancer (RecCC) who received definitive radiochemotherapy including image-guided adaptive brachytherapy (IGABT) as primary treatment are currently treated in our institution with palliative intent by chemotherapy (CHT) combined with bevacizumab...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Strahlenther Onkol
Glavni autori: Sturdza, Alina, Hofmann, Sandra, Kranawetter, Marlene, Polterauer, Stephan, Grimm, Christoph, Krainer, Michael, Kirisits, Christian, Pötter, Richard, Reinthaller, Alexander, Schwameis, Richard
Format: Artigo
Jezik:Inglês
Izdano: Springer Berlin Heidelberg 2017
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5696499/
https://ncbi.nlm.nih.gov/pubmed/28721510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00066-017-1178-x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items